Key facts
- This page summarizes Vinay Shah's Form 4 filing for Virpax Pharmaceuticals, Inc. (VRPX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 31 Jan 2024, 16:25.
Vinay Shah - 29 Jan 2024 Form 4 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- VRPX
- Reported as of
- 29 Jan 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 Jan 2024, 16:25:41 UTC
- Prior SEC filing
- 21 Jun 2023
- Next SEC filing
- 18 Nov 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Vinay Shah
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Vinay Shah filed Form 4 for Virpax Pharmaceuticals, Inc. (VRPX) on 31 Jan 2024.
Change
- Previous filing in this sequence was filed on 21 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VRPX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +112,000
- Change %
- Price
- $0.000000
- Shares after
- 112,000
- Date
- 29 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 112,000
- Exercise price
- $0.3178
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These options vest pro rata on a monthly basis for 36 months commencing one year after the date of grant.
SEC remarks
Exhibit 24.1 - Power of Attorney (Vinay Shah)